000 | 01964 a2200517 4500 | ||
---|---|---|---|
005 | 20250515190219.0 | ||
264 | 0 | _c20091112 | |
008 | 200911s 0 0 eng d | ||
022 | _a1522-1539 | ||
024 | 7 |
_a10.1152/ajpheart.00092.2009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFoudi, Nabil | |
245 | 0 | 0 |
_aAltered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Heart and circulatory physiology _cNov 2009 |
||
300 |
_aH1882-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xanalogs & derivatives |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Abdominal _xdrug effects |
650 | 0 | 4 |
_aAortic Diseases _xcomplications |
650 | 0 | 4 |
_aAtherosclerosis _xenzymology |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aCyclooxygenase 1 _xmetabolism |
650 | 0 | 4 |
_aCyclooxygenase 2 _xbiosynthesis |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEnzyme Induction |
650 | 0 | 4 |
_aEpoprostenol _xmetabolism |
650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aThiophenes _xpharmacology |
650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
700 | 1 | _aNorel, Xavier | |
700 | 1 | _aRienzo, Mario | |
700 | 1 | _aLouedec, Liliane | |
700 | 1 | _aBrink, Charles | |
700 | 1 | _aMichel, Jean-Baptiste | |
700 | 1 | _aBäck, Magnus | |
773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 297 _gno. 5 _gp. H1882-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00092.2009 _zAvailable from publisher's website |
999 |
_c19180302 _d19180302 |